Evidence map›Paper›PMID 37299106›Full record

ArticlePlants (Basel, Switzerland)2023

Assessment of Symptoms of Grapevine Leafroll Disease and Relationship with Yield and Quality of Pinot Noir Grape Must in a 10-Year Study Period.

Cristina Cabaleiro, Ana M Pesqueira, Julián J García-Berrios

Abstract read
In one paragraph

Article in Plants (Basel, Switzerland), 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors.

Cristina CabaleiroEscuela Politécnica Superior de Ingeniería, Departamento de Producción Vegetal y Proyectos de Ingeniería, Campus Terra, Universidade de Santiago de Compostela, 27002 Lugo, Spain.ORCID 0000-0003-4982-0846
Ana M PesqueiraEscuela Politécnica Superior de Ingeniería, Departamento de Producción Vegetal y Proyectos de Ingeniería, Campus Terra, Universidade de Santiago de Compostela, 27002 Lugo, Spain.
Julián J García-BerriosEscuela Politécnica Superior de Ingeniería, Departamento de Producción Vegetal y Proyectos de Ingeniería, Campus Terra, Universidade de Santiago de Compostela, 27002 Lugo, Spain.

Funding

Instituto Nacional de Investigación y Tecnología Agraria y Alimentaria INIA (RTA2008-00078-C03-03)
6 · The paper itself

Abstract

Grapevine leafroll disease (GLD) is caused by one or more of the Grapevine leafroll-associated viruses (GLRaVs). GLD's symptoms are expected to be evident in indicator cultivars, regardless of the GLRaV(s) involved. In the present study, disease incidence (I) and severity (S), symptoms before veraison (Sy < V), a disease severity index (DSI) and an earliness index (EI) (2013-2022) were recorded in order to examine the factors affecting the evolution of GLD in Pinot noir graft inoculated with scions infected with GLRaV-3 that, in origin, showed a diversity of GLD symptoms. Strong correlations between I and S (r = 0.94) and between Sy < V and EI (r = 0.94) were observed; early symptoms proved good predictors of incidence and severity after veraison and of yield and sugar content of the must. The environmental conditions and time after infection did not modify the wide range of symptoms (I: 0-81.5%; S: 0.1-4) that corresponded with the variation in losses (<0-88% for yield and <0-24% for sugar content). With all other factors being constant, the significant differences between plants were mainly due to the GLRaVs present. Plants infected with some GLRaV-3 isolates always had mild symptoms or remained asymptomatic 10 years after grafting but remained a source of infection for GLRaV vectors.

Indexed as

GLRaVgrapevineincidenceleafrolllossesseveritysymptomsvirus

Identifiers

PMID37299106
PMCPMC10255376

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.